You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Poly(ADP ribose)

Showing 26 - 50 of 768
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Solid Tumor, Childhood Solid Tumor, Recurrent Childhood CNS Tumor Trial in United States (Laboratory Biomarker Analysis,

Completed
Has Results
  • Adult Solid Neoplasm
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +21 more
Mar 1, 2021

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

Metastatic Prostate Cancer Trial in Boston (Enzalutamide, Niraparib)

Terminated
Has Results
  • Metastatic Prostate Cancer
  • Boston, Massachusetts
    Tufts Medical Center
Oct 18, 2019

Metastatic Cancer, Unspecified Adult Solid Tumor Trial in Los Angeles (PARP inhibitor BMN-673, temozolomide, irinotecan HCl)

Completed
  • Metastatic Cancer
  • Unspecified Adult Solid Tumor
  • PARP inhibitor BMN-673
  • +4 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Sep 22, 2022

Triple Negative Metastatic Breast Cancer, Advanced Ovarian Cancer, Carboplatin Trial in Belgium, Netherlands, United Kingdom

Active, not recruiting
  • Triple Negative Metastatic Breast Cancer
  • +3 more
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • +3 more
  • Brussels, Belgium
  • +3 more
Dec 19, 2022

Ovarian Cancer Trial in Toronto (Cediranib, Olaparib)

Completed
  • Ovarian Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 3, 2022

Pancreatic Acinar Cell Carcinoma Trial run by the National Cancer Institute (NCI) (Olaparib)

Recruiting
  • Pancreatic Acinar Cell Carcinoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Based on Quantitative Pharmacology in Patients With Pamipril

Not yet recruiting
  • Ovarian Cancer
    • (no location specified)
    Apr 28, 2023

    Pulmonary Arterial Hypertension Trial in Edmonton, Toronto, Quebec City (Olaparib)

    Recruiting
    • Pulmonary Arterial Hypertension
    • Edmonton, Alberta, Canada
    • +2 more
    May 25, 2022

    Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18,

    Recruiting
    • Breast Carcinoma
    • +7 more
    • Computed Tomography
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 24, 2022

    Breast Tumors Trial in Guangzhou (procedure, drug, biological)

    Recruiting
    • Breast Neoplasms
    • Surgery for harvesting tumor-draining lymph nodes
    • +6 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Nov 2, 2023

    Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Boston, Houston

    Recruiting
    • Recurrent Fallopian Tube Carcinoma
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Jan 12, 2023

    Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer Trial in Nanjing (ADT, Abiraterone Acetate,

    Recruiting
    • Neoadjuvant Therapy
    • +3 more
    • Nanjing, Jiangsu, China
      Department of Urology, Drum Tower Hospital, Medical School of Na
    Aug 12, 2022

    Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)

    Not yet recruiting
    • Metastatic Malignant Solid Neoplasm
    • Unresectable Malignant Solid Neoplasm
    • Biopsy
    • +2 more
    • (no location specified)
    Jan 14, 2023

    EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

    Recruiting
    • EGFR-Mutated Non-Small-Cell Lung Carcinoma
    • Small Cell/Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Chicago, Illinois
    • +2 more
    Jan 12, 2023

    Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or

    Completed
    • Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
    • Avelumab Phase 1b
    • +3 more
    • Fayetteville, Arkansas
    • +57 more
    Jan 18, 2023

    Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer Trial in Aurora (Mirvetuximab Soravtansine, Olaparib)

    Not yet recruiting
    • Ovary Cancer
    • +2 more
    • Aurora, Colorado
      University of Colorado Hospital
    May 30, 2023

    Pancreatic Adenocarcinoma, Homologous Recombination Deficiency Trial (Cisplatin)

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • Homologous Recombination Deficiency
    • (no location specified)
    Oct 18, 2023

    Urothelial Cancer Trial in Spain (Niraparib plus Cabozantinib)

    Recruiting
    • Urothelial Cancer
    • Niraparib plus Cabozantinib
    • Barcelona, Cataluña, Spain
    • +10 more
    Feb 8, 2022

    Ovarian Cancer Trial (JPI-547)

    Not yet recruiting
    • Ovarian Cancer
    • (no location specified)
    Jul 24, 2022

    Metastatic Breast Cancer, HER2 Positive Breast Carcinoma Trial in United States (Niraparib, Trastuzumab)

    Recruiting
    • Metastatic Breast Cancer
    • HER2 Positive Breast Carcinoma
    • Birmingham, Alabama
    • +6 more
    Dec 13, 2022

    Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (biological, drug, other)

    Recruiting
    • Biochemically Recurrent Prostate Carcinoma
    • Prostate Adenocarcinoma
    • Durvalumab
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 26, 2023

    Solid Tumor Trial in Belgium, Netherlands, United Kingdom (SYD985 + Niraparib)

    Active, not recruiting
    • Solid Tumor
    • SYD985 + Niraparib
    • Antwerp, Belgium
    • +5 more
    Jan 23, 2023

    Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)

    Recruiting
    • Castration-Resistant Prostate Carcinoma
    • Prostate Adenocarcinoma
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 23, 2022